Vienna, VANCT07223502Now EnrollingIRB Ready

Hypertension (HTN) Clinical Trial in Vienna, VA

Access cutting-edge hypertension (htn) treatment through this clinical trial at a research site in Vienna. Study-provided care at no cost to qualified participants.

Sponsored by Sarfez Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Vienna location

Preparing your pre-screening questions…

Expert Care in Vienna

Access hypertension (htn) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hypertension (htn) treatment provided free

Apply for This Vienna Location

Check if you qualify for this hypertension (htn) clinical trial in Vienna, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Vienna

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Vienna site if eligible
  4. 4Begin participation

About This Hypertension (HTN) Study in Vienna

A study Comparing the Clinical Benefit of Finerenone Versus a Fixed-Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients with Hypertension and Chronic Kidney Disease.

Sponsor: Sarfez Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Adult male and female patients aged ≥18 years;
Are diagnosed with a CKD;
Have an eGFR of ≥25 and ≤60 mL/min/1.72 m2;
Have an UACR 150-3500 mg/g and Sk 4.5 to 5.0 mmol/L;
Have an observed clinic seated systolic blood pressure (SBP) of ≥130 and ≤170 mmHg;
Are receiving up to an 80 mg daily dose of furosemide or an equivalent dose of other loop diuretics and and 10 mg daily dose of finerenone for 30 days;
Willing and able to comply with all aspects of the protocol and to provide written informed consent from the patient or patient's legally acceptable representative (LAR);
Willing to use effective methods of contraception during sexual intercourse with an opposite sex throughout the study.

Exclusion Criteria

Have a diagnosis of type I diabetes mellitus (T1DM);
Have uncontrolled hypertension (SBP \>170 mmHg);
Have primary aldosteronism or endocrine disorders;
Have serum potassium \>5.0 or \<4.5 mmol/L at screening;
Unable to continue on 10 mg finerenone or require daily dose of more than 80mg furosemide or equivalent doses of other loop diuretics
Have a recent diagnosis of acute kidney injury (≤3 months);
Had a cardiovascular event within 3 months prior to screening (e.g., myocardial infarction, stroke, transient ischemic attack, pulmonary embolism, elective coronary artery bypass grafting) or elective percutaneous coronary intervention within 1 month prior to screening;
Had hospitalized for worsening heart failure in last 30 days;
Have an autosomal dominant or recessive polycystic kidney disease;
Have an Addison's disease;
Have Hepatic insufficiency classified as Child-Pugh;
Have a diagnosis of Lupus nephritis or anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis or any other kidney diseases requiring immunosuppressive therapy;
Have a history of organ transplant;
Require treatment with potassium-sparing diuretics;
Have an active malignancy;
Currently taking potassium supplement or potassium binders;
Have known hypersensitivity to sulfonamides or related compounds or spironolactone or finerenone;
Is pregnant, breastfeeding, or planning to become pregnant during the study;
Have participated in another clinical study involving any investigational drug within 30 days prior to Screening;
Is considered to be unsuitable for any other reason that may either place the patient at increased risk during participation or interfere with the interpretation of the study outcomes by the Investigator, after reviewing medical and psychiatric history, physical examination, and laboratory evaluation.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Vienna?

Yes, this clinical trial (NCT07223502) has an active research site in Vienna, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hypertension (HTN) Treatment Options in Vienna, VA

If you're searching for hypertension (htn) treatment options in Vienna, VA, this clinical trial (NCT07223502) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Vienna research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertension (htn) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hypertension (htn) clinical trials near you to find additional studies recruiting in your area.

More Hypertension Trials in Vienna, VA

See all hypertension clinical trials recruiting in Vienna — not just this study.

Browse Hypertension Trials in Vienna →

Browse More Trials by Condition

Hypertension TrialsPulmonary Embolism TrialsAll Conditions →

Ready to Join in Vienna?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Vienna, VA